|
US2616927A
(en)
|
1950-05-12 |
1952-11-04 |
Minnesota Mining & Mfg |
Fluorocarbon tertiary amines
|
|
US4452818A
(en)
|
1982-03-19 |
1984-06-05 |
Haidt Sterling J |
Extraocular method of treating the eye with liquid perfluorocarbons
|
|
US5077036A
(en)
|
1986-01-14 |
1991-12-31 |
Alliance Pharmaceutical Corp. |
Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
|
|
JPS6452722A
(en)
|
1987-05-01 |
1989-02-28 |
Anjierini Pharmaceut Inc |
Ophthalmic composition
|
|
FR2638089A1
(fr)
|
1988-10-26 |
1990-04-27 |
Sandoz Sa |
Nouvelles compositions ophtalmiques a base d'une cyclosporine
|
|
US5518731A
(en)
|
1990-09-27 |
1996-05-21 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery vehicle suspensions
|
|
US6458376B1
(en)
|
1990-09-27 |
2002-10-01 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery suspensions
|
|
US5326566A
(en)
|
1991-05-17 |
1994-07-05 |
Bristol-Myers Squibb Company |
Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
|
|
GB9114374D0
(en)
|
1991-07-03 |
1991-08-21 |
Smithkline Beecham Plc |
Novel process
|
|
FR2679150A1
(fr)
|
1991-07-17 |
1993-01-22 |
Atta |
Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
|
|
US6602900B2
(en)
|
1992-09-21 |
2003-08-05 |
Allergan, Inc. |
Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5336175A
(en)
|
1992-10-29 |
1994-08-09 |
Mames Robert N |
Method for the treatment of retinal detachments
|
|
US5370313A
(en)
|
1994-01-10 |
1994-12-06 |
Beard; Walter C. |
Sterile liquid dispenser
|
|
DE4405627A1
(de)
|
1994-02-22 |
1995-08-24 |
Hoechst Ag |
Fluorkohlenwasserstoffe enthaltende Ölemulsionen
|
|
FR2720943B1
(fr)
|
1994-06-09 |
1996-08-23 |
Applic Transferts Technolo |
Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.
|
|
US6294563B1
(en)
|
1994-10-27 |
2001-09-25 |
Allergan Sales, Inc. |
Combinations of prostaglandins and brimonidine or derivatives thereof
|
|
US5696164A
(en)
|
1994-12-22 |
1997-12-09 |
Johnson & Johnson Consumer Products, Inc. |
Antifungal treatment of nails
|
|
US5667809A
(en)
|
1995-06-07 |
1997-09-16 |
Alliance Pharmaceutical Corp. |
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
|
|
US5874481A
(en)
|
1995-06-07 |
1999-02-23 |
Alliance Pharmaceutical Corp. |
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
|
|
US5578020A
(en)
|
1995-09-01 |
1996-11-26 |
Mosley; Manuel L. |
Drop dispensing apparatus
|
|
DE19536504C2
(de)
|
1995-09-29 |
1999-09-23 |
H Meinert |
Verwendung fluorierter Alkane
|
|
US5874469A
(en)
|
1996-01-05 |
1999-02-23 |
Alcon Laboratories, Inc. |
Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
|
|
US5704906A
(en)
|
1996-02-26 |
1998-01-06 |
Fox; Richard L. |
Method of using a topical anesthetic-cleaning solution and applicator
|
|
FR2752161B1
(fr)
|
1996-08-07 |
1998-09-25 |
Atta |
Emulsions multiples de type hydrocarbure-dans-eau-dans- fluorocarbone pour le transport de substances medicamenteuses hydrophiles et/ou lipophiles
|
|
US5863560A
(en)
|
1996-09-11 |
1999-01-26 |
Virotex Corporation |
Compositions and methods for topical application of therapeutic agents
|
|
IN184589B
(enExample)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
|
US5980936A
(en)
|
1997-08-07 |
1999-11-09 |
Alliance Pharmaceutical Corp. |
Multiple emulsions comprising a hydrophobic continuous phase
|
|
US6335335B2
(en)
|
1997-11-05 |
2002-01-01 |
Senju Pharmaceutical Co., Ltd. |
Prolonged-action eye drop
|
|
US5981607A
(en)
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
|
US6224887B1
(en)
|
1998-02-09 |
2001-05-01 |
Macrochem Corporation |
Antifungal nail lacquer and method using same
|
|
DE19861012A1
(de)
|
1998-03-18 |
1999-09-30 |
Pharm Pur Gmbh |
Behandlungsmittel für die Ophthalmologie
|
|
EP1105096B1
(en)
|
1998-08-19 |
2003-10-29 |
Skyepharma Canada Inc. |
Injectable aqueous dispersions of propofol
|
|
US6140374A
(en)
|
1998-10-23 |
2000-10-31 |
Abbott Laboratories |
Propofol composition
|
|
US6159977A
(en)
|
1998-11-16 |
2000-12-12 |
Astan, Inc. |
Therapeutic anti-fungal nail preparation
|
|
ES2261190T3
(es)
|
1999-02-08 |
2006-11-16 |
Alza Corporation |
Vehiculos viscosos no acuosos estables de fase unica y formulaciones que utilizan dichos vehiculos.
|
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
WO2000054588A1
(en)
|
1999-03-15 |
2000-09-21 |
John Claude Krusz |
Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages
|
|
US6177477B1
(en)
|
1999-03-24 |
2001-01-23 |
American Home Products Corporation |
Propofol formulation containing TRIS
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
DE19926890C1
(de)
|
1999-06-12 |
2000-07-27 |
Pharm Pur Gmbh |
Verwendung eines hochfluorierten oligomeren Alkans in der Ophthalmologie
|
|
DE19938668B4
(de)
|
1999-08-14 |
2006-01-26 |
Bausch & Lomb Inc. |
Tränenersatzmittel
|
|
US6528086B2
(en)
|
1999-09-28 |
2003-03-04 |
Zars, Inc. |
Methods and apparatus for drug delivery involving phase changing formulations
|
|
JP2001158734A
(ja)
|
1999-12-02 |
2001-06-12 |
Lion Corp |
眼科用組成物及びソフトコンタクトレンズに対する吸着抑制方法
|
|
US20030018044A1
(en)
|
2000-02-18 |
2003-01-23 |
Peyman Gholam A. |
Treatment of ocular disease
|
|
DE10024413A1
(de)
|
2000-05-19 |
2001-12-06 |
Mika Pharma Gmbh |
Pharmazeutische und/oder kosmetische Zubereitung
|
|
US6399087B1
(en)
|
2000-12-20 |
2002-06-04 |
Amphastar Pharmaceuticals, Inc. |
Propofol formulation with enhanced microbial inhibition
|
|
US20030027833A1
(en)
|
2001-05-07 |
2003-02-06 |
Cleary Gary W. |
Compositions and delivery systems for administration of a local anesthetic agent
|
|
TWI298257B
(en)
|
2001-05-31 |
2008-07-01 |
Allergan Inc |
Hypotensive lipid and timolol compositions and methods of using same
|
|
KR100757611B1
(ko)
|
2001-09-04 |
2007-09-10 |
트롬스도르프 게엠베하 운트 코. 카게 알츠나이미텔 |
손발톱 성장의 기능장애와 질환을 치료하기 위한 플라스터
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
US7074827B2
(en)
|
2002-10-24 |
2006-07-11 |
Sucampo Ag (Usa) Inc. |
Method for treating ocular hypertension and glaucoma
|
|
AU2003275816A1
(en)
|
2002-11-13 |
2004-06-03 |
Cesar Augusto Cely Lizcano |
A device and method for facilitating the application of liquid material to the eye
|
|
CN1856294A
(zh)
|
2003-08-25 |
2006-11-01 |
弗米克斯有限公司 |
渗透性药物泡沫
|
|
US20050079210A1
(en)
|
2003-10-09 |
2005-04-14 |
Gupta Shyam K. |
Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients
|
|
EP1670433B1
(en)
|
2003-10-10 |
2011-11-23 |
Antares Pharma IPL AG |
Transdermal pharmaceutical formulation for minimizing skin residues
|
|
WO2005051305A2
(en)
|
2003-11-19 |
2005-06-09 |
Barnes-Jewish Hospital |
Enhanced drug delivery
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
CA2563544A1
(en)
|
2004-04-19 |
2005-10-27 |
Centre National De La Recherche Scientifique (C.N.R.S.) |
Lung surfactant supplements
|
|
MXPA06014425A
(es)
|
2004-06-08 |
2007-05-23 |
Ocularis Pharma Inc |
Composiciones oftalmicas hidrofobas y metodo de uso.
|
|
US7063241B2
(en)
|
2004-06-10 |
2006-06-20 |
Allergan, Inc. |
Dispensing tip
|
|
CA2572344A1
(en)
|
2004-07-01 |
2006-01-19 |
Schepens Eye Research |
Compositions and methods for treating eye disorders and conditions
|
|
US7740875B2
(en)
|
2004-10-08 |
2010-06-22 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
US20060078580A1
(en)
|
2004-10-08 |
2006-04-13 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
EP1688161A1
(en)
|
2004-11-02 |
2006-08-09 |
Switch Biotech Aktiengesellschaft |
Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
|
|
US7851504B2
(en)
|
2005-03-16 |
2010-12-14 |
Allergan, Inc. |
Enhanced bimatoprost ophthalmic solution
|
|
GB0511499D0
(en)
|
2005-06-06 |
2005-07-13 |
Medpharm Ltd |
Topical ungual formulations
|
|
BRPI0614084A2
(pt)
|
2005-08-05 |
2011-03-09 |
Bharat Serums & Vaccines Ltd |
composição estável de emulsão de óleo-em-água de propofol, administrável por via intranovesa; e processo de preparação de uma composição
|
|
FR2892023B1
(fr)
|
2005-10-14 |
2009-09-25 |
Galderma Sa |
Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
|
|
DE102005055811A1
(de)
|
2005-11-23 |
2007-05-31 |
Novaliq Gmbh |
Verwendung einer Zusammensetzung zur Konservierung von Organen und Gliedmaßen
|
|
TWI376239B
(en)
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
KR20090053892A
(ko)
|
2006-07-25 |
2009-05-28 |
오스모티카 코프. |
점안액
|
|
US20080039807A1
(en)
|
2006-08-08 |
2008-02-14 |
Jerrold Scott Pine |
Ophthalmic Drug Dispensing Tip
|
|
JP5694664B2
(ja)
|
2006-09-29 |
2015-04-01 |
サーモディクス，インコーポレイティド |
生分解性眼用インプラント及び眼の病気を治療する方法
|
|
EP2099408B1
(en)
|
2006-11-28 |
2016-10-05 |
Wisconsin Alumni Research Foundation |
Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
|
|
US8328775B2
(en)
|
2006-12-07 |
2012-12-11 |
Sun Pharma Advanced Research Company Limited |
Metered drop bottle for dispensing microliter amounts of a liquid in the form of a drop
|
|
EP2178502A2
(en)
|
2007-06-21 |
2010-04-28 |
Yale University |
Sustained delivery of drugs from biodegradable polymeric microparticles
|
|
FR2918891B1
(fr)
|
2007-07-20 |
2009-09-25 |
Thea Sa Lab |
Solution ophtalmique a base de prostaglandines sans conservateur
|
|
US8222292B2
(en)
|
2007-08-06 |
2012-07-17 |
Insys Therapeutics, Inc. |
Liquid cannabinoid formulations
|
|
DE102007055046A1
(de)
|
2007-11-19 |
2009-05-28 |
Fluoron Gmbh |
Infusionslösung
|
|
EP2242504B1
(en)
|
2008-01-09 |
2021-07-14 |
The Schepens Eye Research Institute, Inc. |
Therapeutic compositions for treatment of ocular inflammatory disorders
|
|
DK2110126T3
(da)
|
2008-04-18 |
2012-02-27 |
Novaliq Gmbh |
Inhalations- og instillationsanvendelse af semifluorerede alkaner som aktiv bestanddel-bærere inden for det intrapulmonale område
|
|
US20100006600A1
(en)
|
2008-07-14 |
2010-01-14 |
Dascanio Gustavo A |
Fluid dispenser including hydrophobic ring
|
|
WO2010062394A2
(en)
|
2008-11-26 |
2010-06-03 |
Surmodics, Inc. |
Implantable ocular drug delivery device and methods
|
|
US8501800B2
(en)
|
2009-03-05 |
2013-08-06 |
Insite Vision Incorporated |
Controlled-release ophthalmic vehicles
|
|
IT1393419B1
(it)
|
2009-03-19 |
2012-04-20 |
Medivis S R L |
Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
|
|
WO2010127301A1
(en)
|
2009-05-01 |
2010-11-04 |
Allergan, Inc. |
Method of treating allergic conjunctivitis with cyclosporin compositions
|
|
WO2010146536A1
(en)
|
2009-06-18 |
2010-12-23 |
Koninklijke Philips Electronics N.V. |
Suspension of particles with drug
|
|
WO2010150378A1
(ja)
|
2009-06-25 |
2010-12-29 |
ライオン株式会社 |
眼科用組成物
|
|
JP5736635B2
(ja)
|
2009-06-25 |
2015-06-17 |
ライオン株式会社 |
ドライアイ治療剤
|
|
PT2387391T
(pt)
|
2009-07-24 |
2017-04-20 |
Mika Pharma Ges Für Die Entw Und Vermarktung Pharmazeutischer Produkte Mbh |
Processo para o desenvolvimento de uma composição líquida a ser aplicada na forma de espuma sobre a pele e composição de aplicação tópica
|
|
JP2011024841A
(ja)
|
2009-07-28 |
2011-02-10 |
健太 ▲浜崎▼ |
点眼補助具
|
|
EP2332525A1
(en)
|
2009-11-23 |
2011-06-15 |
Novaliq GmbH |
Pharmaceutical composition comprising propofol
|
|
EP2335735A1
(en)
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmaceutical composition for treatment of dry eye syndrome
|
|
US20110223208A1
(en)
|
2010-03-09 |
2011-09-15 |
Beth Hill |
Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
|
|
ES2564502T3
(es)
|
2010-03-17 |
2016-03-23 |
Novaliq Gmbh |
Composición farmacéutica para el tratamiento de la presión intraocular aumentada
|
|
DE102010022567A1
(de)
|
2010-06-02 |
2011-12-08 |
Fluoron Gmbh |
Zubereitung
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
AU2012204932B2
(en)
|
2011-01-04 |
2017-02-23 |
Novaliq Gmbh |
O/w-emulsions comprising semifluorinated alkanes
|
|
JP6023181B2
(ja)
|
2011-05-25 |
2016-11-09 |
ノバリック ゲーエムベーハー |
爪に投与するための医薬組成物
|
|
JP6039145B2
(ja)
|
2011-05-25 |
2016-12-07 |
ノバリック ゲーエムベーハー |
半フッ化アルカンを基礎にした局所薬学的組成物
|
|
CN104066442B
(zh)
|
2012-01-23 |
2018-05-18 |
诺瓦利克有限责任公司 |
基于半氟化烷烃的稳定蛋白质组合物
|
|
WO2013126602A1
(en)
*
|
2012-02-21 |
2013-08-29 |
Massachusetts Eye & Ear Infirmary |
Inflammatory eye disorders
|
|
US9878000B2
(en)
*
|
2012-06-20 |
2018-01-30 |
University Of Waterloo |
Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
|
|
WO2014008542A1
(en)
|
2012-07-09 |
2014-01-16 |
Brien Holden Vision Institute |
Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
|
|
MX360469B
(es)
|
2012-09-12 |
2018-11-05 |
Novaliq Gmbh |
Composiciones que comprenden mezclas de alcanos semifluorados.
|
|
DE202013012753U1
(de)
|
2012-09-12 |
2019-03-04 |
Novaliq Gmbh |
Zusammensetzungen semifluorierter Alkane zur Verwendung in der Behandlung von Keratoconjunctivitis Sicca
|
|
MX2015007931A
(es)
*
|
2012-12-18 |
2015-10-05 |
Novartis Ag |
Composiciones y metodos que utilizan una etiqueta de peptido que se une a hialuronano.
|
|
EP2783703A1
(en)
|
2013-03-25 |
2014-10-01 |
B. Braun Melsungen AG |
Semifluorocarbon compound containing contrast agent
|
|
WO2015011199A1
(en)
|
2013-07-23 |
2015-01-29 |
Novaliq Gmbh |
Stabilized antibody compositions
|
|
CN106061490A
(zh)
|
2013-10-09 |
2016-10-26 |
列奥尼达斯·A·约翰逊 |
一种治疗和预防眼部疾病症状或体征的方法及组合物
|
|
CA2943255C
(en)
|
2014-03-31 |
2023-01-24 |
Amcor Limited |
Controlled release container
|
|
EP2944324A1
(de)
|
2014-05-13 |
2015-11-18 |
LTS LOHMANN Therapie-Systeme AG |
Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
|
|
EP3179975B1
(en)
|
2014-08-13 |
2024-12-11 |
University of Florida Research Foundation, Inc. |
Preservative removal from eye drops
|
|
WO2016063184A1
(en)
|
2014-10-20 |
2016-04-28 |
Sentiss Pharma Private Limited |
Ophthalmic solution
|
|
WO2016082644A1
(en)
|
2014-11-26 |
2016-06-02 |
The University Of Hong Kong |
A semifluorinated alkane based cleaner for removing emulsified droplets in the eye to reduce the complications associated with the emulsification of silicone oil
|
|
ES2953837T3
(es)
|
2015-09-30 |
2023-11-16 |
Novaliq Gmbh |
2-perfluorobutil pentano para administración oftálmica
|
|
CN120884568A
(zh)
|
2015-09-30 |
2025-11-04 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
|
US10286035B2
(en)
|
2015-10-14 |
2019-05-14 |
Paul Gavaris |
Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
|
|
AU2017275492A1
(en)
|
2016-06-01 |
2018-12-20 |
Harold Richard Hellstrom |
Treatment of dry eye disease with parasympathetic and anti-sympathetic agents
|
|
EP3442480B1
(en)
|
2016-06-23 |
2019-10-02 |
Novaliq GmbH |
Topical administration method
|
|
US11684589B2
(en)
|
2016-09-22 |
2023-06-27 |
Novaliq Gmbh |
Pharmaceutical compositions for use in the therapy of blepharitis
|
|
JP6869336B2
(ja)
*
|
2016-09-23 |
2021-05-12 |
ノバリック ゲーエムベーハー |
シクロスポリンを含む眼科用組成物
|
|
CA3045733C
(en)
|
2016-12-22 |
2024-01-16 |
Novaliq Gmbh |
Compositions comprising tacrolimus for the treatment of intraocular inflammatory eye diseases
|
|
DK3399962T3
(da)
*
|
2016-12-23 |
2020-09-07 |
Novaliq Gmbh |
Oftalmisk sammensætning til behandling af tør øjensygdom
|
|
MX388460B
(es)
|
2017-04-21 |
2025-03-20 |
Dermaliq Therapeutics Inc |
Composiciones de yodo.
|
|
US20210069014A1
(en)
|
2017-05-06 |
2021-03-11 |
Novaliq Gmbh |
Drop dispenser
|
|
CN110650734B
(zh)
|
2017-05-12 |
2024-11-15 |
诺瓦利克有限责任公司 |
治疗与隐形眼镜有关病症的包含半氟化烷烃的药物组合物
|
|
IL273531B2
(en)
|
2017-09-27 |
2024-05-01 |
Novaliq Gmbh |
Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
|
|
US11896559B2
(en)
|
2017-10-04 |
2024-02-13 |
Novaliq Gmbh |
Opthalmic compositions comprising F6H8
|
|
EP3758676A1
(en)
|
2018-03-02 |
2021-01-06 |
Novaliq GmbH |
Pharmaceutical compositions comprising nebivolol
|
|
BR112020017841A2
(pt)
|
2018-03-28 |
2020-12-22 |
Novaliq Gmbh |
Composição farmacêutica que compreende timolol
|
|
JP2021522219A
(ja)
|
2018-04-27 |
2021-08-30 |
ノバリック ゲーエムベーハー |
緑内障の治療のためのタフルプロストを含む眼科用組成物
|
|
KR20210080388A
(ko)
|
2018-09-22 |
2021-06-30 |
노바리크 게엠베하 |
안구 표면 손상 및 건조 증상 치료를 위한 안약 조성물
|
|
US12029757B2
(en)
|
2018-09-27 |
2024-07-09 |
Dermaliq Therapeutics, Inc. |
Lipid barrier repair
|
|
JP7292567B2
(ja)
|
2018-09-27 |
2023-06-19 |
ダーマリック セラピューティクス， インコーポレーテッド |
局所日焼け止め製剤
|
|
WO2020074697A1
(en)
|
2018-10-12 |
2020-04-16 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
|
AU2019390645B2
(en)
|
2018-11-27 |
2025-01-30 |
Novaliq Gmbh |
Semifluorinated alkane compositions comprising omega-3 fatty acid ethyl esters
|
|
US20220008397A1
(en)
|
2019-01-21 |
2022-01-13 |
Novaliq Gmbh |
Pharmaceutical composition for the treatment of ocular neovascularisation
|
|
WO2020165132A1
(en)
|
2019-02-13 |
2020-08-20 |
Novaliq Gmbh |
Compositions and methods for the treatment of ocular neovascularization
|
|
EP3975989A1
(en)
|
2019-05-24 |
2022-04-06 |
Novaliq GmbH |
Ophthalmic composition for the treatment of ocular allergy
|
|
CN114206344A
(zh)
|
2019-08-09 |
2022-03-18 |
诺瓦利克有限责任公司 |
包含前列腺素类似物的局部组合物
|
|
WO2021044045A1
(en)
|
2019-09-06 |
2021-03-11 |
Novaliq Gmbh |
Ophthalmic composition for the treatment of uveitis
|
|
WO2021105392A1
(en)
|
2019-11-27 |
2021-06-03 |
Novaliq Gmbh |
Suspension comprising a protein particle suspended in a non-aqueous vehicle
|